Centro Integral de Medicina Respiratoria (CIMER) - Tucumán
Somos un centro de investigaciones clínicas con más de 30 años de experiencia, buscando una mejor calidad de vida para nuestros pacientes.Centro Integral de Medicina Respiratoria (CIMER) - Tucumán
Combate de San Lorenzo 1241, T4000CBC San Miguel de Tucumán, Tucumán, Argentina
Select an option
I am a doctor
I am a sponsor
Specializations
Neumonología
Reumatología
Nefrología
Neumonología pediátrica
Cardiología
Diagnostico por imágenes (Adultos y niños)
Patients Benefits
Oportunidades de nuevos tratamientos en enfermedades con necesidades insatisfechas
Acceso a especialistas certificados con amplia trayectoria
Un espacio comodo y de fácil acceso
Our team
Authorities
Director médico, subinvestigador, especialista en diagnostico por imágenesGonzalo Hernán Altieri Mohedano
Gerencia-Tecnica espirometríaMaria Veronica Altieri Mohedano
Director médico, investigador principal, neumonólogoHector Hugo Altieri
Director médico, investigador principal, reumatólogoRodolfo Sebastián Perez Alamino
Medical staff
Investigador principal, nefrólogoSantiago Alonso
Subinvestigador-Neumonólogo pediatraSantiago Assaf
Subinvestigadora, neumonólogaMaria Veronica Rojas
Subinvestigadora, reumatólogaPriscila Maria Marcaida
Legal and Administrative staff
SecretariaMagdalena Fernandez
Technical staff
Coordinadora de estudiosNatalia Juarez Babiano
Open studies
Asthma
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma - FLASH - AstraZenecaSee more
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma - INC 54707-208 - Incyte CorporationSee more
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations - FLAIR - Teva Branded Pharmaceutical Products R&D, Inc.See more
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) - VALIANT - Upstream Bio Inc.See more
Chronic obstructive pulmonary disease
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) - PILLAR - Chiesi Farmaceutici S.p.A.See more
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease - THARROS - AstraZenecaSee more
Chronic bronchitis
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) - PILLAR - Chiesi Farmaceutici S.p.A.See more
Lupus
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) - SIRIUS-SLE 2 - Novartis PharmaceuticalsSee more
Pulmonary fibrosis
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis - BEACON-IPF - Pliant Therapeutics, Inc.See more
